West Pharmaceutical ServicesWSTEarnings & Financial Report
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin.
WST Q4 2025 Key Financial Metrics
营收
$805.0M
毛利润
$303.9M
营业利润
$156.6M
净利润
$132.1M
毛利率
37.8%
营业利润率
19.5%
净利率
16.4%
同比增长
7.5%
EPS
$1.82
资金流向
West Pharmaceutical Services Q4 2025 Financial Summary
West Pharmaceutical Services reported revenue of $805.0M for Q4 2025, with a net profit of $132.1M (16.4% margin). Cost of goods sold was $501.1M, operating expenses totaled $147.3M.
Key Financial Metrics
| Total Revenue | $805.0M |
|---|---|
| Net Profit | $132.1M |
| Gross Margin | 37.8% |
| Operating Margin | 19.5% |
| Report Period | Q4 2025 |
West Pharmaceutical Services Annual Revenue by Year
West Pharmaceutical Services annual revenue history includes year-by-year totals (for example, 2025 revenue was $3.1B).
| Year | Annual Revenue |
|---|---|
| 2025 | $3.1B |
| 2024 | $2.9B |
| 2023 | $2.9B |
| 2022 | $2.9B |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $695.4M | $702.1M | $746.9M | $748.8M | $698.0M | $766.5M | $804.6M | $805.0M |
| 同比增长 | -3.0% | -6.9% | -0.1% | 2.3% | 0.4% | 9.2% | 7.7% | 7.5% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $3.60B | $3.49B | $3.68B | $3.64B | $3.62B | $3.95B | $4.11B | $4.27B |
| 总负债 | $921.7M | $912.6M | $923.0M | $961.1M | $935.1M | $1.02B | $1.05B | $1.09B |
| 股东权益 | $2.68B | $2.58B | $2.75B | $2.68B | $2.68B | $2.93B | $3.05B | $3.18B |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $118.2M | $165.0M | $180.1M | $190.1M | $129.4M | $177.1M | $197.2M | $251.1M |
Other Health Care Companies
ALGN
Align Technology
营收
$995.7M
净利润
$56.8M
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
ABBV
AbbVie
营收
$15.8B
净利润
$186.0M
A
Agilent Technologies
营收
$1.9B
净利润
$434.0M
AMGN
Amgen
营收
$9.9B
净利润
$1.3B
BAX
Baxter International
营收
$3.0B
净利润
$-1.1B
BDX
Becton Dickinson
营收
$5.3B
净利润
$382.0M
TECH
Bio-Techne
营收
$295.9M
净利润
$38.0M
BIIB
Biogen
营收
$2.3B
净利润
$-48.9M
BSX
Boston Scientific
营收
$5.3B
净利润
$670.0M